Apollo Hospitals CFO says the restructuring and listing of its digital and pharmacy businesses will be completed by the last quarter of FY27, after approvals from regulators including SEBI and NCLT.
Hospital shares were in demand on Monday amid reports that the health ministry revised rates for nearly 2,000 medical procedures under the Central Government Health Services (CGHS) scheme.
Once niche and costly, genomic testing is becoming affordable across India as prices fall 30-40 per cent, with hospitals and diagnostic chains expanding into Tier-2 and Tier-3 cities
Multiple triggers could help Apollo Hospitals to reverse underperformance
Stocks to Watch today: Apollo Hospitals, Adani Power, Dr Reddy's Labs, BPL, Texmaco Rail and Vedanta are among the stocks to watch today, September 15, 2025
Apollo Hospitals shares fell after 1.32 per cent equity changed hands on NSE in two pre-market block trades
Apollo Hospitals MD Suneeta Reddy plans to sell her 1.25% stake worth Rs 1,395 crore through block deals, reducing her holding to 2.11%
For Q1FY26, Apollo Hospitals' consolidated revenue grew 15 per cent year-on-year (Y-o-Y) to ₹5,842 crore, driven by all three business segments.
F&O stocks: For Apollo Hospitals, the short-term trend is positive as it is placed above its 5, 11 and 20-day EMA.
Apollo and Siemens Healthineers will collaborate on AI and imaging research for early detection, diagnosis, and monitoring of liver diseases including MASLD in India
Apollo anticipates a 140 basis points hit to operating profit margins in FY26 due to new hospitals
Apollo Hospitals Enterprise shares rose on the back of strong performance for the quarter ended March 31, 2025 (Q4FY25), with a year-on-year (Y-o-Y) growth across key financial indicators.
Apollo's Q4 PAT surged 54% to ₹389.6 crore on strong patient volumes and revenue growth; FY25 profit up 61%, with ₹8,000 crore investment planned over 5 years
The Chennai-based hospital chain is also working on an AI tool that will help clinicians prescribe the most effective antibiotic suitable to treat the illness
Apollo Hospitals' consolidated profit rose 51.8 per cent year-on-year (Y-o-Y) to Rs 372.3 crore in Q3FY25, from Rs 245.3 crore in the same quarter previous fiscal year (Q3FY24)
Apollo Hospitals, Vijaya Diagnostic and Narayana Hrudayalaya have given a fresh breakout on the daily scale. Charts show that these 5 healthcare related shares can rally up to 11 per cent.
Stocks to watch on November 7, 2024: Apollo Hospitals Enterprise reported Q2FY25 net profit of Rs 380 crore, up from Rs 233 crore Y-o-Y
Shares of Apollo Hospitals hit a lifetime high at Rs 7,435.40 per share on the BSE, zooming 6.67 per cent in Thursday's intraday deals
Shares of Apollo Hospitals Enterprise (AHEL) rose 2.92 per cent to Rs 6,711.95 per share on the BSE in Friday's early morning trade
The markets traded lackluster and ended slightly lower, continuing the ongoing consolidation phase. After a flat start, the Nifty fluctuated within a narrow range, eventually closing at 24,413.50.